Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets

Since 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been rapidly spreading worldwide, causing hundreds of millions of infections. Despite the development of vaccines, insufficient protection remains a concern. Therefore, the screening of drugs for the treatment of coronaviru...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Pei-Chen, Huang, Chen-Hao, Kuo, Chih-Jung, Liang, Po-Huang, Wang, Lily Hui-Ching, Pan, Max Yu-Chen, Chang, Sui-Yuan, Chao, Tai-Ling, Ieong, Si-Man, Fang, Jun-Tung, Huang, Hsuan-Cheng, Juan, Hsueh-Fen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779140/
https://www.ncbi.nlm.nih.gov/pubmed/35057070
http://dx.doi.org/10.3390/pharmaceutics14010176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779140/
https://www.ncbi.nlm.nih.gov/pubmed/35057070
http://dx.doi.org/10.3390/pharmaceutics14010176

Ejemplares similares